ReCept Pharmacy Receives Specialty Pharmacy Accreditation by URAC - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
ReCept Pharmacy Receives Specialty Pharmacy Accreditation by URAC


ReCept Pharmacy Receives Specialty Pharmacy Accreditation by URAC

PR Newswire

FORT WORTH, Texas, Sept. 4, 2014 /PRNewswire/ -- ReCept Pharmacy, LP has been granted full Specialty Pharmacy Accreditation by URAC, a Washington, DC-based healthcare accrediting organization. The URAC accreditation process exemplifies a commitment to quality services, provides a framework to improve business processes, and promotes best practices through benchmarking organizations against nationally-recognized healthcare standards.

ReCept Pharmacy has been granted full Specialty Pharmacy Accreditation by URAC

 In addition to meeting the mandatory accreditation requirements, ReCept Pharmacy also achieved URAC's Leading Indicator status by satisfying all of the optional elements which highlight practices not yet widely adopted in healthcare. These leading indicators, a prediction of where the healthcare industry may be heading, provide ReCept with a further differentiator from other accredited organizations.

"ReCept is honored to receive Specialty Pharmacy Accreditation from URAC," said Carmine DeNardo, President and CEO of ReCept Pharmacy. "We are very pleased to be recognized in the industry – such a distinction underscores the quality of our work by demonstrating compliance with national standards for a Specialty Pharmacy."

"ReCept Pharmacy is dedicated to comprehensive care with disease-specific clinical education and the implementation, maintenance and monitoring of compliance programs," said Jason Lynn, Vice President of Clinical Services and Trade Relations at ReCept Pharmacy. "Every day, ReCept pharmacists pledge to provide our patients with the best care possible."

"We applaud ReCept Pharmacy on achieving URAC Specialty Pharmacy Accreditation," said URAC President and CEO, Kylanne Green. "It is critically important for healthcare organizations to make a commitment to quality and accountability. URAC accreditation is a demonstration of that commitment."

By attaining URAC Specialty Pharmacy Accreditation, ReCept has better positioned itself to strategically expand within and proactively respond to today's rapidly evolving healthcare industry while continuing to deliver superior patient care.

For more information about URAC, call 202-216-9010 or visit www.urac.org.

About ReCept Pharmacy:
ReCept Pharmacy is a fast growing specialty retail pharmacy with over 35 years of pharmacy experience serving the Southwestern United States.   ReCept employs a knowledgeable, dedicated clinical staff to manage patients with complex chronic conditions.  ReCept specializes in serving patients and their treating physicians within the therapeutic classes of Autoimmune, Hepatitis, HIV, Oncology, Compounding and Pain Management.  Taking a holistic approach to patient management, ReCept understands specific disease states, their treatments and the effects those treatments have on individual patients.  An avid commitment to keep patients adherent and compliant with their treatment regimen is ongoing.  The ReCept corporate mission is simple: "To make people feel better" and improve their overall quality of life.  For additional information on ReCept Pharmacy, please visit our website at: www.receptrx.com .

ReCept Pharmacy's Helping Hands Logo symbolizes the organization's dedication to "making people feel better".

Logo - http://photos.prnewswire.com/prnh/20140903/142588
Logo - http://photos.prnewswire.com/prnh/20140429/82049

SOURCE ReCept Pharmacy, LP

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

UPCOMING CONFERENCES

8th Annual Forum on Transparency and Aggregate Spend 2014
Washington, DC
August 18-20, 2014

eSource Data in Clinical Investigations
Philadelphia, PA
August 20-21, 2014

Pharmacovigilance 2014
Philadelphia, PA
September 10-11, 2014

Collaborative Research Summit
Philadelphia, PA
October 15-16, 2014

See All Conferences >>

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
86%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
7%
View Results
Untitled Document

Click here